R. Scott Struthers is President, Chief Executive Officer and Director of Crinetics Pharmaceuticals, Inc. (CRNX). The company reported total compensation of $11,628,959 for fiscal year 2025.
| Salary | $718,500 |
|---|---|
| Bonus | $0 |
| Stock awards | $3,280,540 |
| Option awards | $7,160,564 |
| Non-equity incentive plan | $462,355 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $7,000 |
| Total | $11,628,959 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Crinetics Pharmaceuticals, Inc. filed April 29, 2026, accession 0001658247-26-000030.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Director | $718,500 | $0 | $3,280,540 | $7,160,564 | $462,355 | $0 | $7,000 | $11,628,959 |
| FY2024 | President and Chief Executive Officer | $653,833 | — | $2,828,150 | $6,640,800 | $407,796 | — | $3,000 | $10,533,579 |
| FY2023 | President and Chief Executive Officer | $614,000 | — | $1,210,806 | $3,558,849 | $361,339 | — | $3,000 | $5,747,994 |
Totals as disclosed in each year's own compensation disclosure for Crinetics Pharmaceuticals, Inc..
| Peer-group chief executive median | $14,944,585 |
|---|---|
| Difference from that median | $-3,315,626 |
| Percentile within the disclosed peer group | 36th |
| Peers with a disclosed figure | 11 |
Medians and percentiles are computed across the peer group Crinetics Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| R. Scott Struthers this page | President, Chief Executive Officer and Director | $11,628,959 |
| Tobin Schilke | Chief Financial Officer | $4,357,893 |
| Dana Pizzuti | Chief Medical and Development Officer | $3,910,331 |
| Stephen Betz | Chief Scientific Officer | $3,827,148 |
| Jeff Knight | Chief Operating Officer | $3,826,671 |
| Marc Wilson | Former Chief Financial Officer | $3,255,392 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Crinetics Pharmaceuticals, Inc. compensation brief.
R. Scott Struthers's compensation sits inside Crinetics Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Crinetics Pharmaceuticals, Inc. (CRNX) compensation brief